Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Psioxus Therapeutics Limited patents


Recent patent applications related to Psioxus Therapeutics Limited. Psioxus Therapeutics Limited is listed as an Agent/Assignee. Note: Psioxus Therapeutics Limited may have other listings under different names/spellings. We're not affiliated with Psioxus Therapeutics Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Psioxus Therapeutics Limited-related inventors


Oncolytic adenovirus encoding a b7 protein

The present disclosure provides a replication competent oncolytic adenovirus with selectivity for cancer cells, wherein the adenovirus comprises a transgene under the control of a promoter endogenous to the virus, wherein the transgene comprises a dna sequence encoding a b7 protein or an active fragment thereof, compositions comprising same, methods of generating the viruses, and use of the viruses and compositions in treatment, particularly in the treatment of cancer.. . ... Psioxus Therapeutics Limited

Oncolytic adenovirus encoding a therapeutic protein or active fragment

The present disclosure provides a oncolytic adenovirus with selectivity for cancer cells, wherein the adenovirus comprises a transgene under the control of a promoter endogenous to the virus, wherein the transgene comprises a dna sequence encoding a membrane anchored anti-cd3 antibody or a binding fragment thereof, compositions comprising same, methods of generating the viruses, and use of the viruses and compositions in treatment, particularly in the treatment of cancer.. . ... Psioxus Therapeutics Limited

Multi-valent adjuvant display

The present invention provides an adjuvant-polymer construct comprising a polymer backbone which is covalently linked to 3 or more adjuvants, wherein the 3 or more adjuvants are each present in a pendant side chain, the adjuvants being connected to the polymer backbone either directly or via a spacer group.. . ... Psioxus Therapeutics Limited

Process for the preparation of group b adenoviruses

The present disclosure relates to a process for the manufacture of adenovirus having a fibre and hexon of subgroup b (such as ad11, in particular ad11p also known as the slobitski strain) wherein the e4 region completely present or completely deleted said process comprises the steps: a. Culturing mammalian cells infected with the adenovirus in the presence of media suitable for supporting the cells such that the virus replicates, wherein the cells are capable of supporting viral replication, and b. ... Psioxus Therapeutics Limited

Oncolytic adenovirus encoding a b7 protein or active fragment

The present disclosure provides a replication competent oncolytic adenovirus with selectivity for cancer cells, wherein the adenovirus comprises a transgene under the control of a promoter endogenous to the virus, wherein the transgene comprises a dna sequence encoding a b7 protein or an active fragment thereof, compositions comprising same, methods of generating the viruses, and use of the viruses and compositions in treatment, particularly in the treatment of cancer.. . ... Psioxus Therapeutics Limited

Psioxus Therapeutics Limited

. . ... Psioxus Therapeutics Limited








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Psioxus Therapeutics Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Psioxus Therapeutics Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###